Germany· DE-A57-c8b00802b8957c2d
Oralair
A medicinal product containing allergen extract from pollen of dactylis glomerata, anthoxanthum odoratum, lolium perenne, poa pratensis and phleum pratense, registered in Germany by Stallergenes.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Allergen Extract From Pollen Of Dactylis Glomerata, Anthoxanthum Odoratum, Lolium Perenne, Poa Pratensis And Phleum Pratense
- Manufacturer
- Stallergenes
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb635798-d57e-43f5-a29e-29f15d742b96 GET /v1/drugs/eb635798-d57e-43f5-a29e-29f15d742b96?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Sublingual Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Allergen Extract From Pollen Of Dactylis Glomerata, Anthoxanthum Odoratum, Lolium Perenne, Poa Pratensis And Phleum Pratense",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about allergen extract from pollen of dactylis glomerata, anthoxanthum odoratum, lolium perenne, poa pratensis and phleum pratense.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.